iRhythm Technologies Q2 2024 Adj. EPS $(0.61) Beats $(0.89) Estimate, Sales $148.000M Beat $146.206M Estimate
Portfolio Pulse from Benzinga Newsdesk
iRhythm Technologies (NASDAQ:IRTC) reported better-than-expected Q2 2024 results with an adjusted EPS of $(0.61) beating the $(0.89) estimate and sales of $148.000 million surpassing the $146.206 million estimate. Sales increased by 19.23% year-over-year.
August 01, 2024 | 8:09 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
iRhythm Technologies reported better-than-expected Q2 2024 results, with an adjusted EPS of $(0.61) beating the $(0.89) estimate and sales of $148.000 million surpassing the $146.206 million estimate. Sales increased by 19.23% year-over-year.
The better-than-expected earnings and sales figures, along with a significant year-over-year sales increase, are likely to positively impact iRhythm Technologies' stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100